Mr. Shah Coherent Market Insights Pvt. Ltd. + 12524771362 email us here Visit us on social media: LinkedIn Facebook X ...

The US Army has launched the Executive Innovation Corps under Detachment 201 to recruit tech leaders from Palantir, Meta, and ...

Please enter your username and password below, if you are not yet a member of BioTechniques remember you can register for ...

Viome is combining science and AI to provide dietary advice and detect diseases. Two company execs share how they use the MVP ...

The biotech’s pivotal phase 2 trial is assessing ... “given that it utilizes a different AAV vector (AAVrh74) and does not include the C3 inhibitor in its immunosuppression protocol.” ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Plant biotechnology can be defined as the introduction of desirable traits into plants through genetic modification. High-efficiency leucoplast transit peptides are identified and shown to enhance ...

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical ...

In the past 60 days, loss estimates for Immunocore’s 2025 have improved from $1.57 to 86 cents per share. Loss per share estimates for 2026 have narrowed from $1.80 to $1.34 during the same ...

The FDA has designated the viral vector rAAVrh74, which Sarepta Therapeutics, Inc. (NASDAQ:SRPT) uses in its gene therapy candidate SRP-9003 for limb-girdle muscular dystrophy type 2E/R4 (LGMD2E ...